Compare3 funds · 3 pairs
Picked · 3YTD
Every pair · 3Won · shared
Close to theseFee · YTD
Best of the threeNov 9
  • Lowest cost$ a year on $10kSCHD 0.06%
  • Most incometrailing 12-month yieldSCHD 2.96%
  • Best 5 yearsper yearXLK +17.1%
  • Smallest drop · 1Yworst fall in the past yearSCHD −6.9%
Measures won1–5SCHD wins · of 6 · 5Y
$10,000 · 5Y$21,984XLK · SCHD $16,459
Lowest cost0.06%SCHD · $6 on $10k
Most income2.96%SCHD · $296 on $10k
Smallest drop−6.9%SCHD · worst fall in 1Y
Held in common0.0%BBC and SCHD

BBC vs SCHD

5Y
BBC
SCHD
Virtus Biotech Clinical Trials ETF · $28MSchwab U.S. Dividend Equity ETF · $122B
+36.2%3 years · per year$25,261 · $17,123+19.6%
+0.2%5 years · per year$10,101 · $16,459+10.5%
0.65%Expense ratio$65 · $6 on $10k · lower wins0.06%
1.46%12-mo yield$146 · $296 on $10k2.96%
−30.2%Worst dropSmaller wins−6.9%
38.8%VolatilityLower wins11.8%
1–5SCHD wins
$10,000 · 5 yearsAll three, one scale
$10k startXLK $22.0kSCHD $16.5kBBC $10.1kNov 2021Nov 2026
Shared top holdingsBBC · SCHD

They share no top holdings, or holdings aren’t on file […]

Held in common0.0%
End-of-day Nov 9, 2026 · $10,000 5 years ago, dividends reinvested · ● winner of the row · each row scaled to the bigger of the two
@TheETFTracker·theetftracker.com

All Three

5Y3 funds
#Trend
1XLKState Street Technology Select Sector SPDR ETFReadDesk0.08%0.49%+3.7%+19.1%+18.8%+27.0%+17.1%−19.6%$109.6B
2BSCHDSchwab U.S. Dividend Equity ETFReadDesk0.06%2.96%+1.4%+33.2%+39.1%+19.6%+10.5%−6.9%$121.7B
3ABBCVirtus Biotech Clinical Trials ETFReadDesk0.65%1.46%+4.6%+16.7%+52.4%+36.2%+0.2%−30.2%$28M
End-of-day Nov 9, 2026 · total return, dividends in · 3Y and 5Y per year · A and B = the pair in versus
@TheETFTracker·theetftracker.com

Cards for this view

BBC vs SCHD

5Y
Virtus Biotech Clinical Trials
$10,101
Schwab U.S. Dividend Equity
$16,459
$5k$10k$15kNov 2021Nov 2026$10,101$16,459$5k$10k$15kNov 2021Nov 2026$10,101$16,459
MeasureBBCSCHD
Fee0.65%0.06%
Cost on $10k a year$65$6
Yield1.46%2.96%
5 years, per year+0.2%+10.5%
3 years, per year+36.2%+19.6%
Worst drop · 1Y−30.2%−6.9%
Volatility · 1Y38.8%11.8%
5–1measures won
SCHD first
0.0%
holdings shared
Nov 9, 2026 · $10,000 five years ago, dividends reinvested
@TheETFTracker·theetftracker.com

SCHD vs VIG

YTD
SchwabSCHD
+33.2%
VIGVanguard
+14.8%
Jan 1Nov 9+33.2%+14.8%
+33.2%Year to date+14.8%
3.0%Yield1.5%
$122BAssets$109B
2–0SCHD wins
End-of-day Nov 9, 2026
@TheETFTracker·theetftracker.com

XLK vs VGT

YTD
SPDRXLK
+19.1%
VGTVanguard
+19.3%
Jan 1Nov 9+19.1%+19.3%
+19.1%Year to date+19.3%
0.08% · $8Fee · on $10k a year0.09% · $9
$110BAssets$155B
1–1level
End-of-day Nov 9, 2026
@TheETFTracker·theetftracker.com

JEPQ vs JEPI

YTD
J.P. MorganJEPQ
+6.6%
JEPIJ.P. Morgan
+7.5%
Jan 1Nov 9+6.6%+7.5%
+6.6%Year to date+7.5%
12.4%Yield7.9%
$40.7BAssets$45.2B
1–1level
End-of-day Nov 9, 2026
@TheETFTracker·theetftracker.com

Overlap: BBC, SCHD, XLK

Today
3.9%most shared, SCHD and XLK
BBCSCHDXLK
BBC—0.0%0.0%
SCHD0.0%—3.9%
XLK0.0%3.9%—
End-of-day Nov 9, 2026 · share held in common · outlined: the pair in versus
@TheETFTracker·theetftracker.com

Income After Fees on $10,000

1Y
$290most kept, SCHD
SCHD$296 − $6 = $290
BBC$146 − $65 = $81
XLK$49 − $8 = $41
KeptFee
End-of-day Nov 9, 2026 · yield in dollars minus the fee
@TheETFTracker·theetftracker.com